# Aprepitant to Improve Same Day Discharge for TKA

> **NCT07639723** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Endeavor Health** · enrollment: 350 (estimated)

## Conditions studied

- PONV

## Interventions

- **DRUG:** Aprepitant Injection
- **DRUG:** Ondansetron (Zofran)
- **DRUG:** Dexamethasone
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT07639723
- **Lead sponsor:** Endeavor Health
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-07
- **Primary completion:** 2027-07
- **Final completion:** 2027-08
- **Target enrollment:** 350 (ESTIMATED)
- **Last updated:** 2026-06-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07639723

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07639723, "Aprepitant to Improve Same Day Discharge for TKA". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07639723. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*